What industries do you specialize in?

We focus exclusively on healthcare B2B companies—including health tech platforms, medical device manufacturers, clinical service providers, pharmaceutical partners, and payer organizations navigating value-based care markets.

How is this different from a traditional consulting firm?

We're operators, not theorists. Every strategy we recommend has been tested in real healthcare markets. We focus on implementation-ready frameworks and stay engaged through execution, not just strategy documents. Our team brings deep commercial experience from top 10 pharma companies.

What does a typical engagement look like?

We start with deep market analysis and strategic planning, then move to building your growth infrastructure—messaging, targeting, multi-channel systems. Most clients see qualified leads within 60-90 days and continue with ongoing optimization support.

How do you measure success?

We track qualified leads generated, meeting conversion rates, partnership acquisition velocity, pipeline growth, and revenue impact. Everything is transparent and tied to your business objectives.

What makes your healthcare expertise different?

Our team has extensive experience at top 10 pharma companies across Medical Affairs, HEOR, and market access. We speak the language of KOLs, clinicians, and payers—not generic sales speak. We've managed complex, data-heavy healthcare teams and know how to translate clinical evidence into commercial wins.

All insights

HealthTech Consulting

HealthTech Go-To-Market: The Playbook for 2026 Buyers

July 16, 20267 min read

A 2026 GTM playbook for selling into health systems, payers, and pharma — built around trust signals, not demos.

The buyer has changed

Health-system CIOs, CMOs, and value-analysis committees buy on risk reduction, not on feature lists. Your GTM motion has to match.

Trust signals beat demos

Published outcomes, KOL endorsements, peer reference sites, and security/compliance posture move deals further than another demo.

Pilot-to-contract conversion

Pilots fail commercially when there is no pre-agreed path to enterprise contract. Build that path into the pilot SOW from day one.

Channel partners

GPOs, IDNs, and EHR marketplaces are not distribution — they are trust accelerators. Treat them like KOLs of the buyer's procurement function.

Ready to put this into practice?

We embed with HealthTech, pharma, and medical device commercial teams as growth partners — not consultants. Start with a 10-minute Trust Audit or book a discovery call.

Book a discovery call Take the Trust Audit